Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of the STAT3 signaling transduction pathways in radioresistance
Po‐Chang Shih
Pharmacology & Therapeutics (2022) Vol. 234, pp. 108118-108118
Closed Access | Times Cited: 21

Showing 21 citing articles:

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 157
Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy
Fawad Ur Rehman, Yang Liu, Qingshan Yang, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 696-708
Closed Access | Times Cited: 64
X‐Ray‐Responsive Zeolitic Imidazolate Framework‐Capped Nanotherapeutics for Cervical Cancer‐Targeting Radiosensitization
Shuya Pan, Guanning Huang, Zhengwei Sun, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 13
Closed Access | Times Cited: 32
Biomineralization-Tuned Nanounits Reprogram the Signal Transducer and Activator of Transcription 3 Signaling for Ferroptosis-Immunotherapy in Cancer Stem Cells
Youbo Zhao, Yang Fei, Yang Zhao, et al.
ACS Nano (2024) Vol. 18, Iss. 32, pp. 21268-21287
Closed Access | Times Cited: 8
Unravelling the role of NFE2L1 in stress responses and related diseases
Xingzhu Liu, Chang Xu, Wanglong Xiao, et al.
Redox Biology (2023) Vol. 65, pp. 102819-102819
Open Access | Times Cited: 18
Therapeutic application of manganese-based nanosystems in cancer radiotherapy
Shuya Pan, Zhengwei Sun, Bo Zhao, et al.
Biomaterials (2023) Vol. 302, pp. 122321-122321
Closed Access | Times Cited: 18
The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone
Zeyang Shao, Heng Wang, Haiyan Ren, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5678-5678
Open Access | Times Cited: 15
Radiotherapy opens the blood–brain barrier and synergizes with anlotinib in treating glioblastoma
Peijing Li, Shuzhen Lai, Ting Jin, et al.
Radiotherapy and Oncology (2023) Vol. 183, pp. 109633-109633
Closed Access | Times Cited: 13
Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapy
Boping Jing, Feng Guo, Rui An, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11
SNORA28 Promotes Proliferation and Radioresistance in Colorectal Cancer Cells through the STAT3 Pathway by Increasing H3K9 Acetylation in the LIFR Promoter
Xin Liu, Hong Zhang, Ying Fan, et al.
Advanced Science (2024) Vol. 11, Iss. 32
Open Access | Times Cited: 3
Maternal embryonic leucine zipper kinase in tumor cells and tumor microenvironment: An emerging player and promising therapeutic opportunity
Bufu Tang, Ruochen Yan, Siwei Wang, et al.
Cancer Letters (2023) Vol. 560, pp. 216126-216126
Closed Access | Times Cited: 6
Sinularin Induces Oxidative Stress-Mediated Apoptosis and Mitochondrial Dysfunction, and Inhibits Angiogenesis in Glioblastoma Cells
Shih‐Yuan Hsu, Zhi‐Hong Wen, Po‐Chang Shih, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1433-1433
Open Access | Times Cited: 11
Development of decoy oligonucleotide-warheaded chimeric molecules targeting STAT3
Po‐Chang Shih, Miyako Naganuma, Genichiro Tsuji, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 95, pp. 117507-117507
Closed Access | Times Cited: 5
6-O-endosulfatases in tumor metastasis: heparan sulfate proteoglycans modification and potential therapeutic targets
Mengzhen Han
American Journal of Cancer Research (2024) Vol. 14, Iss. 2, pp. 897-916
Open Access | Times Cited: 1
A redox-responsive nanosystem to suppress chemoresistant lung cancer through targeting STAT3
Qiyi Feng, Jie Chen, Jinxing Huang, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 349-360
Closed Access | Times Cited: 3
HSF1 is involved in immunotherapeutic response through regulating APOJ/STAT3-mediated PD-L1 expression in hepatocellular carcinoma
Hongxia Cheng, Sikai Wang, Aidan Huang, et al.
Cancer Biology & Therapy (2022) Vol. 24, Iss. 1, pp. 1-9
Open Access | Times Cited: 5
Involvement of RAGE in radiation-induced acquisition of malignant phenotypes in human glioblastoma cells
H Seki, Kazuki Kitabatake, Sei‐ichi Tanuma, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 9, pp. 130650-130650
Open Access
Effect of napabucasin and doxorubicin via the Jak2/Stat3 signaling pathway in suppressing the proliferation of neuroblastoma cells
İlker Ünlü, Mehmet Cudi Tuncer, İlhan Özdemir
Acta Cirúrgica Brasileira (2024) Vol. 39
Open Access
MicroRNA-450b-5p modulated RPLP0 promotes hepatocellular carcinoma progression via activating JAK/STAT3 pathway
Yanqiu Meng, Xianbin Huang, Guangxin Zhang, et al.
Translational Oncology (2024) Vol. 50, pp. 102150-102150
Closed Access
Napabucasin Inhibits Proliferation and Migration of Glioblastoma Cells (U87) by Regulating JAK2/STAT3 Signaling Pathway
İlker Ünlü, İlhan Özdemir, Mehmet Cudi Tuncer
Medicina (2024) Vol. 60, Iss. 10, pp. 1715-1715
Open Access
An immortalized adipose-derived stem cells line from the PIK3CA-related overgrowth spectrum: Unveiling novel therapeutic targets
Bin Sun, Hongrui Chen, Wei Gao, et al.
Biochemistry and Biophysics Reports (2024) Vol. 40, pp. 101869-101869
Closed Access
Page 1

Scroll to top